Alere™ i Influenza A & B delivers molecular flu results in less than 15 minutes on our unique Alere™ i platform; making it significantly faster than other molecular methods and more accurate than conventional rapid tests. Rapid diagnostic tests with increased sensitivity are essential for the reliable detection of influenza A and B and enable immediate, effective treatment decisions.
The Alere™ i Influenza assay was the first ever molecular assay to be granted CLIA waiver.
Alere™ i Strep A provides molecular results in 8 minutes, allowing you to confidently test, and with a positive result, treat during the patient’s visit, thus enabling real-time clinical decisions which may impact patient care.
Alere™ i RSV delivers molecular RSV results in 13 minutes or less on the Alere™ i platform.